Logo1
PSHP - 47th Annual Assembly
Mr pencil

How would you like your name to appear on your certificate?



What activities did you attend at the event?
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
PHARMACISTS AND PHARMACY TECHNICIANS ONLY -- Please provide the following:
NABP eProfile ID (ePID):
Date of Birth (MM/DD) - Example September 24 would be 0924:
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Objective 1: Provide pharmacists and technicians with updates in disease state and drug therapy management
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
Please rate the following:
The program was relevant to my work.
Content matched stated objectives.
Usefulness of handouts/AV.
Quality of facilities.
How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?
If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain in detail (e.g. session title, speaker name, situtation):
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Objective 3: Provide pharmacists and technicians with updates in the area of patient safety
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Describe the current state and future direction of PSHP related to pharmacists
Summarize key points from the ASHP House of Delegates meeting relating to pharmacists
Discuss current trends in pharmacy practice
Review the components of the Pennsylvania Pharmacy Technician Bill and how it applies to pharmacists
Describe the current state and future direction of PSHP for pharmacy technicians
Summarize key points from the ASHP House of Delegates meeting for pharmacy technicians
Discuss current trends in pharmacy practice and opportunities for technicians
Review the components of the Pennsylvania Pharmacy Technician Bill and the changes that may occur for technicians
Describe recent advancements in microbiology rapid diagnostic testing
Review current literature describing the impact of rapid diagnostic testing on antimicrobial stewardship programs and patient outcomes
Evaluate the incorporation of rapid diagnostics into an antimicrobial stewardship program to identify bacteremia in a teaching hospital
Describe antimicrobial stewardship and the technician role for assisting pharmacists in this process
State what rapid diagnostic testing is and what it is used for
Define bacteremia and state the medications used for treatment
Identify at least three differences between small molecule drugs and biologics
Evaluate the clinical evidence for the filgrastim biosimilar
Describe the role of the pharmacist in making hospital formulary decisions and pharmacovigilance
Discuss the potential impact on U.S. health economy with the approval and use of biosimilars
Define small molecule drugs and biologics
State the indication for filgrastim
Describe the role of the technician in managing biosimilar inventories
Identify indicators that predict the continued growth of ambulatory care
Describe the role of the pharmacist in successful contemporary practice models
Describe key metrics being utilized in Ambulatory Care practices and how pharmacists can impact these measures
Discuss Provider Status and evolution of the Ambulatory Care practice model
Describe the evolution of ambulatory care pharmacy practice model and the new roles that will exist
Identify the metrics that will need to be monitored and collected to show evidence of the impact of the pharmacy team within an ambulatory care setting
Discuss Provider Status and the impact it will have on the change in position responsibilities of the various pharmacy team members
List 3 benefits for pharmacists of establishing a pharmacy internship program
Identify the steps to create a pharmacy internship program
State 3 challenges for pharmacists to implementing a pharmacy internship program
List 3 reasons for establishing a pharmacy internship program with technician involvement in training and education
Identify how to establish a pharmacy internship program with technician involvement in training and education
List 3 challenges in establishing a pharmacy internship program with technician involvement in training and education
Identify the key stakeholders in the medication reconciliation process
Evaluate a medication list and determine whether medications are appropriate for inpatient use
Describe future directions and opportunities for pharmacy personnel in medication reconciliation
List the strategies for optimizing medication reconciliation
Identify an open-ended question
Describe primary and secondary sources in obtaining a medication history
Describe the challenges involved in obtaining a medication list
List the strategies for optimizing medication reconciliation
Explain the concept of home infusion practice
List three tasks associated with completion of a successful home infusion referral
Define the process of care planning medication reconciliation
Recite the number of home infusion pharmacies currently in operation
List four parenteral therapies commonly provided at home
List three intravenous catheter types used to provide home infusion therapy
Explain the justification for an Emergency Department Pharmacist
Describe the core roles of the Emergency Department Pharmacist (EDP)
Describe strategies for implementing an EDP position
Identify how to encourage growth in the specialty of Emergency Medicine (EM) pharmacy
Describe some ways in which EDPs can systematically improve the care of patients in ED
Explain the need for pharmacy presence in the Emergency Department
Describe pharmacy technician roles for the Emergency Department
Describe ways in which technicians can improve patient care in the Emergency Department
Describe the pharmacist role in collaborative practice
Explain how pharmacist led-MTDM programs decrease costs of healthcare
Give examples of how pharmacist led-MTDM programs improve quality and safety of healthcare
List roles of pharmacy technician in MTM program
Explain principles of pharmacy technician in MTM program
Describe desirable organizational structure for a system wide MTM Program
Discuss at least 3 examples of clinical and operational metrics that are meaningful to measure for a health-system pharmacy department
Review challenges and potential solutions in the collaborative practice setting
Summarize the purpose and goals of the HCAHPS survey
Discuss the role of the pharmacist in developing oncology practice
Identify transition of care opportunities for inpatient pharmacists
Describe operational metrics that apply to pharmacy technician performance
Discuss the role of technicians in collaborative practice agreements
Identify how technicians can impact patient experience in the hospital setting
Discuss the role of the technician in developing oncology practice
Discuss the role of the technician in transition of care
Discuss basic understanding of second victim phenomenon
Inform all staff of available support resources: such as Human Resources, Employee Assistance Programs during various venues including but not limited to staff meetings, campaigns, safety walkrounds, huddles, and National Patient Safety week programs
Describe how this program meets Joint Commission standards in Leadership and Patient Safety
Describe the process to design, develop and implement a structured second victim support program at a medical facility or department without any increase in FTEs
Discuss basic understanding of second victim phenomenon
Identify signs and symptoms of second victim
Discuss what types of emotional care are needed to support an employee or peer through a traumatic event
Discuss value of narratives /storytelling /staff personal reflections /simulation training to engage trainees
Examine data related to Hazardous Drug contamination in the work place and its effects on healthcare workers
Review the current Safe Handling Standards, Recommendations and Regulations from USP, NIOSH, OSHA, ASHP and ONS relevant to pharmacists
Categorize hazardous drugs and design a process for handling them in a specific facility
Identify and Communicate to others, risks related to handling hazardous drugs
Examine data related to Hazardous Drug contamination in the work place and its effects on healthcare workers
Review the current Safe Handling Standards, Recommendations and Regulations from USP, NIOSH, OSHA, ASHP and ONS relevant to technicians
Locate and Interpret safe handling resources, both internal and external documents
Assess work situations for safety
Communicate to others, risks related to handling hazardous drugs
Review the physiological effects of a continuous-flow left-ventricular assist device (CF-LVAD)
Understand the role of pharmacotherapy in the management of CF-LVADs
Evaluate clinical symptoms and device findings in the diagnosis of CF-LVAD complications
Describe the pharmacotherapy in the treatment of device-related complications
Define what a CF-LVAD is and why it is used
List the different medications used for patients with CF-LVADs
List the potential complications of CF-LVADs
Name the different medications used in the treatment of complications of CF-LVADs
Identify individuals who were instrumental in building our current pharmacy foundation
Review the transition of pharmacists from dispensing to direct patient care
Describe changes in pharmacist education and practice in the last 40 years
Discuss future opportunities and direction for pharmacy students and pharmacists
Identify individuals who were instrumental in building our current pharmacy foundation
Review the transition for technicians from dispensing to direct patient care
Describe changes in technician education and practice
Discuss future opportunities and direction for technician students and technicians
Please tell us about any session you found particularly good or bad
Please tell us about any objective you feel we accomplished well or poorly. 
Please tell us about any presenter you found particularly good or bad
Please answer the following:
Do you believe this activity was appropriate for the scope of your professional activities?
Was the educational content scientifically sound?
If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?
Was the mode of education effective to learning?
If you answered "No" to any of the above questions, please explain.
Did you perceive any product/service/company/commercial bias in any educational session you attended or materials you received?
If you answered "Yes" to the above question, please detail the situation below (e.g. session title, speaker name):
Were you solicited by sales personnel in an educational room (other areas do not matter) while you attended this educational activity?
If you answered "Yes" to the above question, please explain in detail (e.g. who, when, where):
How much did you learn as a result of this education program?
What specifically did you learn during this activity that you intend to integrate into your practice?

What questions have arisen in your practice for which you need answers/strategies that you can implement?

What patient/client problems or patient/client challenges do you feel you are not able to address appropriately or to your satisfaction?
What problems are your patients/clients communicating to you that need attention or follow up?

Are you interested in basic, intermediate or advanced level trainings?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training (the overall meeting) be improved to better impact competence, performance and/or patient/client outcomes?

Additional comments:

Mr question